Destiny Pharma. Share Price (DEST)

Share Name Share Symbol Market Type Share ISIN Share Description
Destiny Pharma. LSE:DEST London Ordinary Share GB00BDHSP575 ORD GBP0.01
  Price Change % Change Share Price Shares Traded Last Trade
  -1.00p -1.27% 78.00p 7,988 15:34:46
Bid Price Offer Price High Price Low Price Open Price
76.00p 80.00p 79.00p 78.00p 79.00p
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Pharmaceuticals & Biotechnology -3.21 -8.40 34.0
Related Shares
AstraZeneca (AZN), GlaxoSmithKline (GSK), Venn Life (VENN), Port Erin (PEBI)

Destiny Pharma. (DEST) Latest News (2)

Destiny Pharma. News

Date Time Source Headline
19/10/201807:31ALNCFAlliance News Flash Headline
19/10/201807:00RNSNONDestiny Pharma PLC BIA celebrates UK bioscience innovative
26/9/201812:39ALNCDestiny Pharma Loss More Than Doubles On Administrative Expenses
26/9/201807:01UKREGDestiny Pharma PLC Interim results for six months ended 30 June 2018
26/9/201807:01UKREGDestiny Pharma PLC Dr Jesús Gonz z appointed Chief Medical Officer
06/9/201813:24ALNCDestiny Pharma Chairman Nigel Rudd To Step Down In December
06/9/201807:01UKREGDestiny Pharma PLC Directorate Change
26/7/201813:49ALNCDestiny Pharma Receives Positive Results From Skin Irritation Study
26/7/201807:01UKREGDestiny Pharma PLC Positive Phase 1 skin irritation study with XF-73
17/7/201810:42ALNCDestiny Pharma Teams With University To Examine XF-Platform Compounds
More Destiny Pharma. News
Destiny Pharma. Takeover Rumours

Destiny Pharma. (DEST) Share Charts

1 Year Destiny Pharma. Chart

1 Year Destiny Pharma. Chart

1 Month Destiny Pharma. Chart

1 Month Destiny Pharma. Chart

Intraday Destiny Pharma. Chart

Intraday Destiny Pharma. Chart

Destiny Pharma. (DEST) Discussions and Chat

Destiny Pharma. Forums and Chat

Date Time Title Posts
05/10/201811:54Destiny Pharma plc30

Add a New Thread

Destiny Pharma. (DEST) Most Recent Trades

Trade Time Trade Price Trade Size Trade Value Trade Type
14:34:3276.257,9886,090.85O
View all Destiny Pharma. trades in real-time

Destiny Pharma. (DEST) Top Chat Posts

DateSubject
19/10/2018
09:20		Destiny Pharma. Daily Update: Destiny Pharma. is listed in the Pharmaceuticals & Biotechnology sector of the London Stock Exchange with ticker DEST. The last closing price for Destiny Pharma. was 79p.
Destiny Pharma. has a 4 week average price of 78p and a 12 week average price of 78p.
The 1 year high share price is 169.25p while the 1 year low share price is currently 78p.
There are currently 43,562,598 shares in issue and the average daily traded volume is 3,388 shares. The market capitalisation of Destiny Pharma. is £33,978,826.44.
Read Full Thread
Reply
05/10/2018
11:54		edmonda: new analysis on pipeline's development and expansion, with increased fair value as a result (a multiple of current share price). Plenty of news expected in coming weeks, too. Note freely accessible here: https://www.equitydevelopment.co.uk/edreader/?ltkn=5f3dec7ebec4cbdaf80bd7d872a074b0AvbosF0F&d=%3D%3DAO4QjM
Read Full Thread
Follow
Reply
02/10/2017
14:47		jonwig: At the risk of being a boor, I'll repeat my post #7 from four weeks ago: I saw the initial RNS and looked at the website. Basically their compounds appear to act so quickly that bacteria have no time to develop resistance via mutation. My immediate reaction to this was extreme scepticism. It appears to suggest that antibiotic resistant mutations happen when bacteria are stimulated by exposure to an agent. But this isn't the case: they happen purely randomly. Indeed there will already exist resistant strains, and resistant populations will develop and increase by natural selection as happens with current antibiotics. I met a biochemist last week (on holiday) whose discipline is immunology, so not quite the same, and he confirmed that my general understanding was correct. Obviously I need to do more study on this and it would be good to see if the company's research has been peer-reviewed. (A lot of these companies don't allow that.) I know their early trials have been successful, and I may be off-beam here, but I wouldn't want to invest in anything I didn't understand. I just can't find any corroborative information about their compounds (Help anyone?), and first results should be some time away. (How much?) Until then, it's unlikely the share price will do more than respond to speculative froth. A trigger will be phase results, and it's unlikely these can leak as they should be double-blind and reported immediately. When they are, how many here will understand them? More to the point, they seem to have £14m cash with a burn of £2m pa (but that will increase). At least they won't have to scramble.
Read Full Thread
Follow
Reply
Destiny Pharma. share price data is direct from the London Stock Exchange
add chat code
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:41 V: D:20181019 18:08:15